RESEARCH TRIANGLE PARK, N.C. — Clinipace, a developer of software for use in late-stage clinical research studies, has won a contract with a registry led by researchers at the University of North Carolina at Chapel Hill.

The Antiphospholipid Syndrome Collaborative Registry (APSCORE), which is managed by investigators at the Thurston Arthritis Research Center in the School of Medicine at UNC, will use Clinipace’s software to collect and update clinical, demographic and laboratory data on patients with Antiphospholipid Syndrome (APS) nationwide.

APS is an immune system disorder affecting the blood.

Clinipace’s Tempo software will be used to handle four years of data.